MedMira Introduces VYRA TriDemic

Author's Avatar
Dec 30, 2022

HALIFAX, NS / ACCESSWIRE / December 29, 2022 / Today, MedMira Inc. (MedMira) (TSXV:MIR, Financial) presents its latest addition to the VYRATM product line, the VYRATM TriDemic Antigen Rapid Test for the simultaneous detection of SARS-CoV-2, Flu A, Flu B and Respiratory Syncytial Virus (RSV). VYRA TriDemic, a four-in-one test, which is a direct response to the rise of RSV cases globally.